Search

The rise of financial technology has been a positive theme of late. With that in mind, these five fintech ETFs are worth your consideration.

Relative Performance (RP) measures how a stock is performing relative to a specific index and is a good sign of strength or weakness.

Auto stocks have been on a tear the last few weeks as Tesla (TSLA) has been in a downturn. It’s not merely a coincidence.

The government shutdown stock market rally was an ironic coincidence. It was also the latest evidence of how immune stocks are to short-term trends.

It’s time to sell EMAN. I think eMagin remains a mediocre company that has excellent technology and which will continue to have modest success in its military markets. But I don’t think this is “the next big thing.”

Today, Goldman Sachs Group (GS) reported a tremendous third quarter, with earnings per share (EPS) of $4.88 vs. Wall Street’s consensus estimate of $3.82, and up 47% vs. $2.90 EPS a year ago (December year-end).

This biopharmaceutical firm acquires, rebrands and reprices drugs for sale in the U.S., with many that treat inflammatory conditions, including a few that take aim at rare diseases.

The healthcare industry has had its share of ups and downs, with most of the attention being showered on the biotechs that hope to produce COVID-19 vaccines. But after the recent outlook upgrade of today’s recommendation, investors may want to broaden their healthcare watch list.

For now our positions remain in great shape, and this week we are adding a stock that we successfully traded in March, and has shown no signs of pulling back after an earnings blowout last week.

Today’s recommendation had been in a slow, steady uptrend for years, though it got dented with everything else in March of this year.

Cabot explains how the Dow could reach 14,000 in 2011.

Morgan Stanley Capital International (MSCI) has decided to open one of its global indexes to Chinese stocks. For emerging markets investors, it’s good news.

The best contrarian stocks often emerge from a place of serious, albeit temporary, scorn and ridicule. United Continental (UAL) is the most recent example.

MarketWatch reports that Cabot Market Letter owes its strong performance in 2007 to market timing and stock selection.

Investors hate being told to do nothing. And when the market is chopping up and down like a roller coaster, it’s especially hard. Maybe you want to pick up some screaming bargains, or maybe you’re itching to sell everything at any price. But those times, when the market has no...

Stock market predictions are easy to make. They’re also utterly meaningless - and potentially dangerous if you listen to them.

The big news in the marijuana industry this week is that the Tilray/Aphria merger is complete, turning these two Canadian firms into the biggest marijuana company in the world—for now.

We’re making some portfolio adjustments today.

Paul Goodwin tells why growth investors need a disciplined sell strategy.